Why does laser microdissection isolation matter for target validation in neurodegeneration?

Laser microdissection enables precise isolation of neuromelanin granules from substantia nigra tissue, allowing proteomic analysis of dopaminergic neurons preferentially lost in Parkinson's disease. This supports target validation by providing disease-relevant protein profiles from the affected neuronal population. The method reduces tissue requirements, making it feasible to study precious post-mortem human samples.

How does automated granule selection fit into the discovery pipeline for biomarker identification?

Automated selection of neuromelanin granules via field of view analysis and RGB thresholding standardizes isolation, reducing user bias and increasing reproducibility. This fits into the discovery pipeline by enabling consistent sample preparation for proteomic screening campaigns. The approach supports biomarker identification by ensuring comparable granules are analyzed across healthy and disease conditions.

What quantitative proteomic measurements enable condition comparison in this workflow?

Label-free quantification (LFQ) and intensity-based absolute quantification (iBAQ) measurements enable quantitative comparison of protein abundance between neuromelanin granules and surrounding substantia nigra tissue. These metrics allow researchers to identify differentially abundant proteins, such as cytoplasmic dynein-1 heavy chain 1, which showed higher iBAQ values in granules. The measurements support data-driven target prioritization and mechanistic insights.

Why do replication requirements matter for cross-functional collaboration in omics studies?

Replication requirements ensure that proteomic findings from laser microdissected granules are robust and reproducible across experiments, which is essential for cross-functional collaboration between proteomics, biology, and data science teams. Consistent results build confidence in target validation efforts and reduce false positives. The protocol's overlap of 87.6% with a prior LMD-based study demonstrates its reliability for multi-team projects.

What statistical analysis capabilities are required before implementing this proteomic workflow?

Before implementation, teams require capabilities for label-free quantification (LFQ) data processing, including normalization, missing value imputation, and statistical testing for differential expression. The workflow uses MaxQuant with LFQ and iBAQ options, requiring familiarity with proteingroups.txt output processing. Teams must also be able to filter decoys, contaminants, and validate results using total ion current for low-sample scenarios.

뉴로멜라닌 과립의 단백질체 프로파일의 LC-MS/MS 분석을 위한 레이저 미세 해부 기반 프로토콜

2.3K views

Cited by 4

07:35 min

December 16th, 2021

10.3791/63289-v

December 16th, 2021

2.3K views

Maximilian Wulf¹^,² , Katalin Barkovits-Boeddinghaus¹^,² , Paula Sommer¹^,² , Karin Schork¹^,² , Martin Eisenacher¹^,² , Peter Riederer³^,⁴ , Manfred Gerlach⁵ , Steffen Kösters¹^,² , Britta Eggers*¹^,² , Katrin Marcus*¹^,²

¹Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, ²Medical Proteome Analysis, Center for Proteindiagnostics (PRODI), Ruhr-University Bochum, ³Center of Mental Health; Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, ⁴Psychiatry Department of Clinical Research, University of Southern Denmark Odense University Hospital, ⁵Center of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Wuerzburg, University of Wuerzburg

레이저 미세 해부를 통해 인간 사후 흑질 관절 조직으로부터 뉴멜라닌 과립을 분리하기 위한 강력한 프로토콜이 여기에 제시되어 있습니다. 이 개정 및 최적화된 프로토콜은 샘플 수집에 필요한 시간을 크게 최소화하고 필요한 샘플 양을 줄이며 LC-MS/MS 분석을 통해 단백질의 식별 및 정량을 향상시킵니다.